Skip to main content
Clinical Trials/IRCT20190209042660N1
IRCT20190209042660N1CompletedPhase 3

A clinical trial on comparing morbidity and mortality of restrictive blood transfusion strategy with a traditional strategy in patients with a thermal burn

Iran University of Medical Sciences0 sites40 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to no limit (—)
Sex
All

Inclusion Criteria

  • Age over 18 years
  • Total Body Surface Area more than 20 percent
  • Admission to the burn center where the study took place in first 96 hours after the injury

Exclusion Criteria

  • a known history of allergic reactions secondary to blood transfusions
  • history of requiring hemodialysis
  • Brain death
  • Angina or acute myocardial infarction
  • known history of hematologic disorder
  • blood transfusion at another center prior to admission
  • those who were unlikely to survive, according to the experienced burn specialists
  • impaired coagulation

Investigators

Similar Trials